Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 3 Issue: 3, June

The MYC Oncogene as a Cancer Drug Target

Volume:3   Issue: 3
Pp: 163-175
Heiko Hermeking
DOI: 10.2174/1568009033481949
Published on: 01 March, 2012

Gab1, SHP-2 and Other Novel Regulators of Ras: Targets for Anticancer Drug Discovery?

Volume:3   Issue: 3
Pp: 177-192
Armelle Yart, Patrick Mayeux and Patrick Raynal
DOI: 10.2174/1568009033481976
Published on: 01 March, 2012

Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action

Volume:3   Issue: 3
Pp: 193-203
M. Abal, J. M. Andreu and I. Barasoain
DOI: 10.2174/1568009033481967
Published on: 01 March, 2012

Tumor Angiogenesis: A Potential Target In Cancer Control by Phytochemicals

Volume:3   Issue: 3
Pp: 205-217
Rana P. Singh and Rajesh Agarwal
DOI: 10.2174/1568009033481985
Published on: 01 March, 2012

Short-Chain Fatty Acid Inhibitors of Histone Deacetylases: Promising Anticancer Therapeutics?

Volume:3   Issue: 3
Pp: 219-236
James S. Chen, Douglas V. Faller and Remco A. Spanjaard
DOI: 10.2174/1568009033481994
Published on: 01 March, 2012

Erratum

Volume:3   Issue: 3
Pp: 237-237

DOI: 10.2174/1568009033481958
Published on: 01 March, 2012